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Abstract: Pulmonary emphysema is characterized by the irreversible loss of pulmonary alveoli. 
Despite recent advances in the understanding this disease, its treatment remains palliative. In 
this review, we will successively review the data suggesting (1) that alveolar regeneration 
systems are functional in the mammalian lung and have the potential to regrow lost alveoli, 
(2) that cigarette smoke, the main etiologic factor of emphysema, inhibits those systems under 
experimental conditions, and (3) that alveolar regeneration systems are dysfunctional in the 
human emphysematous lung and may be a target for therapeutic intervention in this disease. 
Special emphasis will be put on the role of alveolar ﬁ  broblasts in those processes.
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Introduction
Pulmonary emphysema is characterized by the progressive destruction of pulmonary 
alveoli. It is one of the most common diseases worldwide (Halbert et al 2006) and its 
incidence keeps growing along with the large diffusion of its main etiologic factor, 
tobacco smoking. The ever-increasing use of tobacco in the developing world allows for 
the prediction of a huge increase in the number of cases in the near and distant future. 
The prognosis of pulmonary emphysema is poor, with airﬂ  ow limitation progressing 
to chronic respiratory insufﬁ  ciency, disability and premature death.
To this day, therapeutic options for pulmonary emphysema are few and scarcely 
effective. Patients who stop smoking do beneﬁ  t in terms of lung function and survival, 
but the decline in lung function is not reversed, merely slowed. Apart from long-term 
oxygen therapy, pharmacological intervention is unsatisfactory and is mainly limited to 
the control of symptoms related to frequently-associated chronic bronchitis (Sutherland 
and Cherniack 2004). Lung volume reduction surgery can be of interest in selected 
patients (Fishman et al 2003) as may be the implantation of endobronchial one-way 
valves (Wood et al 2007) but those techniques do not remedy the underlying condition. 
Lung transplantation, while beneﬁ  cial in terms of symptoms-related quality of life, 
does not improve survival in patients with pulmonary emphysema (Hosenpud et al 
1998). Overall, treatment of pulmonary emphysema is palliative.
Most studies of the pathogenesis of emphysema focused on the mechanisms 
involved in chronic injury induced by cigarette smoke to the pulmonary parenchyma. 
In particular, the role of protease-antiprotease imbalance, persistent inﬂ  ammation, oxi-
dative stress and excessive apoptosis of alveolar cells was demonstrated (Barnes et al 
2003). However, while great advances were made towards the comprehension of those 
phenomenons, they have not translated into new therapeutic prospects until now.
Alveolar regeneration systems may be important actors in the course of emphysema. 
On the one hand, alterations or defects in those systems may account for the deﬁ  ciency 
in tissue repair which is observed in the emphysematous lung. On the other hand, 
the induction of alveolar regeneration would be an interesting therapeutic target in International Journal of COPD 2007:2(4) 464
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this disease. In this review, we will successively assess the 
evidence (1) that alveolar regeneration systems are functional 
in the mammalian lung and have the potential to regrow lost 
alveoli, (2) that cigarette smoke, the main etiologic factor 
of emphysema, inhibits those systems under experimental 
conditions, and (3) that alveolar regeneration systems are 
dysfunctional in the human emphysematous lung and may be 
a target for therapeutic intervention in this disease. Special 
emphasis will be put on the role of alveolar ﬁ  broblasts in 
those processes.
Effective alveolar regeneration 
systems are functional in the adult 
mammalian lung
The potential for alveolar generation and regeneration in adult 
mammals was only recently demonstrated in rodents but also 
in larger animals. This phenomenon could be observed after 
alveolar depletion was induced either diffusely by starvation 
or locally by the surgical resection of lung parenchyma.
Alveolar regeneration has been observed in mice fed a 
normal diet after a starvation period. Starvation has long 
been known to induce the loss of pulmonary alveoli and the 
subsequent development of emphysema-like lesions in the 
lung as was recently shown in humans with anorexia nervosa 
(Coxson et al 2004). There are no data regarding the potential 
reversibility of these lesions in humans, however the return to 
a normal diet induces the complete resolution of starvation-
associated emphysema in mice (Massaro et al 2004). This 
phenomenon represents a truly regenerative process as the 
restoration of normal numbers and surface of alveoli is 
accompanied by a sharp elevation of DNA synthesis in the 
lung, indicating cellular replication (Massaro et al 2007).
Alveolar regeneration was also demonstrated after a local-
ized resection of lung parenchyma. Indeed, the knowledge 
that the remaining lung undergoes adaptative changes and 
compensatory alveolar generation after lung resection was 
acquired several decades ago (Cagle and Thurlbeck 1988). 
In rats, resection of the upper and middle lobes of the right 
lung (25% of the total lung volume) induces a sharp increase 
in the volume of the remaining lobes, while microscopically 
alveolar size and surface are close to those of unoperated 
animals, indicating the de novo generation of alveoli (Wandel 
et al 1983). In mice, post-resection alveolar generation 
involves all cellular components of the lung as epithelial, 
endothelial and mesenchymal cells proliferate (Voswinckel 
et al 2004). It must be emphasized that in this context the 
newly formed alveolar tissue seems to be functional and to 
participate in ventilation.
Of major interest, compensatory alveolar generation 
after lung resection was also evidenced in growth–arrested 
species, albeit to a lesser degree than in rodents. In dogs as 
well as in humans, the intensity of post-pneumonectomy 
alveolar generation seems to depend on age. In young 
dogs, after left pneumonectomy removing less than 45% of 
total lung parenchyma, compensatory alveolar generation 
occurs vigorously and leads to the restoration of alveolar 
numbers similar to that of unoperated animals (Takeda 
et al 1999). By contrast, in fully adult dogs, a stronger 
stimulus such as right pneumonectomy (removing 55% 
or more of parenchyma) is needed to induce a weaker and 
incomplete response (Hsia et al 1994). In humans, post-
pneumonectomy alveolar generation and lung growth do 
not seem to occur in adults but indirect clues point towards 
the existence of such phenomenon in children and to a 
lesser degree in adolescents. In particular, the ventilatory 
function at adulthood of patients pneumonectomized before 
the age of 4 is close to that of unoperated subjects, most 
likely indicating that the formation of new alveoli com-
pensated for resected ones (Laros and Westermann 1987). 
Patients operated upon between 6 and 20 years of age still 
had better lung function parameters than those of patients 
who underwent pneumonectomy at adulthood (Laros and 
Westermann 1987). Altogether, those results indicate that 
alveolar regeneration systems are present in the lung of 
growth-arrested mammals such as humans, and that those 
systems are accessible to stimulation.
Mechanisms of alveolar 
regeneration, role of alveolar 
ﬁ  broblasts
Alveolar cells of every type (epithelial, endothelial, and 
mesenchymal) participate in alveolar multiplication and 
regeneration events since those require their equilibrated 
proliferation. Moreover, all three main cell types seem to 
possess the ability to drive lung growth since the administra-
tion of growth factors targeted towards either type leads to 
the acceleration of alveolar generation after lung resection. 
The hepatocyte growth factor (HGF), the ﬁ  rst such agent that 
was identiﬁ  ed as stimulating lung growth after lung resection 
(Yanagita et al 1993), targets both epithelial and endothelial 
cells. The epidermal growth factor (EGF) (Kaza et al 2000), 
activates mainly epithelial cells, whereas the platelet–derived 
growth factor-BB (PDGF-BB) (Yuan et al 2002) is a mitogen 
primarily for mesenchymal cells. While both the keratinocyte 
growth factor (KGF) (Kaza et al 2002), and the vascular 
endothelial growth factor (VEGF) (Sakurai et al 2006) International Journal of COPD 2007:2(4) 465
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stimulate post-pneumonectomy alveolar multiplication, the 
former induces proliferation exclusively in epithelial cells 
while the latter essentially targets the endothelium. Alto-
gether, those results suggest that the induction of proliferation 
in a particular cell population of alveoli may be accompanied 
by the simultaneous expansion of the other neighboring cell 
types, possibly through paracrine mechanisms. However, 
some elements indicate that mesenchymal cells may be ﬁ  rst 
among equals and may play a leading part in those processes. 
Indeed, pulmonary ﬁ  broblasts are the main contributors to 
the synthesis and maintenance of the alveolar extracellular 
matrix which is the essential scaffold over which other cells 
proliferate and differentiate and which provides the lung with 
its essential mechanical characteristic, elasticity. Moreover, 
alveolar ﬁ  broblasts secrete growth factors targeting alveolar 
epithelial and endothelial cells.
Pulmonary ﬁ  broblasts are the main cell type responsible 
for the synthesis and secretion of the main components of 
the alveolar extracellular matrix, proteoglycan, collagen and 
elastin. Elastin in particular is an essential component of 
the alveolar extracellular matrix as it provides the lung with 
the elasticity needed for ventilation, and it is probable that 
elastin synthesis is an essential step in alveolar growth and 
regeneration. Supporting this hypothesis, Koh and colleagues 
(Koh et al 1996) showed that tropoelastin mRNA was sharply 
overexpressed in the lung of rats after pneumonectomy, and 
that its expression was localized to the ends, bends and junc-
tions of alveolar walls, indicating that the de novo synthesis 
of elastic ﬁ  bers was part of the process of alveolar growth 
and multiplication. In this study, the localization of lung 
elastin mRNA expression after pneumonectomy differed 
slightly from that observed in developing animals as in the 
latter case elastin mRNA expression was observed at the 
end and bend of alveolar walls but was not observed at the 
junctions of alveolar walls.
In addition to their role as extracellular matrix providers, 
alveolar fibroblasts seem to participate in the complex 
cellular interactions that lead to alveolar growth and mul-
tiplication both in the fetal lung (Warburton and Bellusci 
2004) and in the adult lung. Fibroblasts interact both with 
endothelial cells and epithelial cells through the secretion 
of soluble factors that act in a paracrine fashion. In particu-
lar, ﬁ  broblasts are the main if not the only source of KGF 
in the distal lung and contribute greatly to the elevation of 
lung HGF levels in response to alveolar injury (Stern et al 
2000; Marchand-Adam et al 2003, 2005; Cohen et al 2006). 
Moreover, although this point has not been demonstrated 
in adult animals so far, lipid-laden interstitial ﬁ  broblasts, 
a subpopulation of alveolar ﬁ  broblasts, are the main source 
of retinoic acid in the lungs of rodents undergoing alveolar 
septation (McGowan and Torday 1997). In adult animals, 
retinoic acid, the active metabolite of vitamin A, increases 
post-pneumonectomy lung growth in rodents (Kaza et al 
2001) and enhances alveolar capillary formation after right 
pneumonectomy in dogs (Yan et al 2004).
Interestingly, the role of ﬁ  broblasts in the regulation of 
cell-cell interactions in alveoli may not be limited to the 
secretion of paracrine signal molecules as cytoplasmic expan-
sions originating in those cells reach alveolar endothelial and 
epithelial cells through their respective underlying basement 
membranes (Sirianni et al 2003).
Overall, ﬁ  broblasts seem to play a central role in alveolar 
multiplication and regeneration and it may be assumed that 
the realization of such phenomenon requires proliferating 
and metabolically active ﬁ  broblasts.
Cigarette smoke represses 
ﬁ  broblast functions implicated 
in alveolar regeneration and repair
Cigarette smoke is responsible for an overwhelming majority 
of cases of pulmonary emphysema. The mechanisms by 
which chronic smoke exposure induces chronic lung injury 
leading to emphysema have been exhaustively described and 
include chronic inﬂ  ammation (Hoidal and Niewoehner 1982), 
protease/antiprotease imbalance (Carp and Janoff 1978), 
oxidative stress (Church and Pryor 1985) and excessive death 
of bronchiolar and alveolar epithelial and endothelial cells 
(Jung et al 2000; Tuder et al 2000; Wickenden et al 2003). 
However, the role of cigarette smoke in the pathogenesis of 
emphysema does not seem to be limited to its participation 
in chronic injury to the lung. Indeed, cigarette smoke has 
been shown to reduce viability in human lung ﬁ  broblasts and 
to inhibit a number of ﬁ  broblast functions closely linked to 
alveolar regeneration, at least in vitro.
Cigarette smoke possesses cytotoxic properties towards 
lung fibroblasts as cigarette smoke extract reduces the 
viability of those cells in vitro (Ishii et al 2001). This effect 
has been linked to the induction of apoptosis (Carnevali et al 
2003; Baglole et al 2006). Additionally, cigarette smoke 
inhibits lung ﬁ  broblast proliferation and their capacity to 
migrate (Nakamura et al 1995; Nobukuni et al 2002). More-
over, lung ﬁ  broblasts chronically exposed to cigarette smoke 
display a senescent phenotype characterized by an enlarged 
morphology and cell cycle arrest (Nyunoya et al 2006). 
Altogether, those results indicate that cigarette smoke proba-
bly induces a reduction in the number of metabolically active International Journal of COPD 2007:2(4) 466
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ﬁ  broblasts available for alveolar growth and multiplication 
in the emphysematous lung.
In addition to its cytotoxic and antiproliferative effects, 
cigarette smoke inhibits key ﬁ  broblastic functions associated 
with alveolar growth and multiplication. In particular, elastin 
synthesis and cross-linking seem to be especially sensitive 
to exposure to cigarette smoke. While no data are available 
regarding adult lung ﬁ  broblasts, cigarette smoke extract down 
regulates tropoelastin mRNA in rat fetal lung ﬁ  broblasts (Gao 
et al 2005). In an acellular model, cigarette smoke inhibits 
elastin cross-linking (Laurent et al 1983), while the transcrip-
tion of lysyl oxidase, a key effector of elastin cross-linking 
is reduced in fetal rat lung ﬁ  broblasts exposed to cigarette 
smoke extract (Gao et al 2005).
Whether cigarette smoke exposure antagonizes alveolar 
growth and multiplication in vivo has not been demonstrated 
directly. To our knowledge, no study has been dedicated 
to the description of the effect of cigarette smoke on post-
pneumonectomy lung growth. However, data obtained in 
a different model of alveolar depletion, elastase-induced 
emphysema, indicate that cigarette smoke exposure may 
indeed induce a defect in elastin synthesis and cross-linking, 
alveolar growth, multiplication and/or repair. Indeed, while 
elastase instillation in the trachea induces a sharp elevation 
in elastin synthesis in the lung, this response is reduced by 
40% in the lung of hamsters exposed to cigarette smoke 
for one week (Osman et al 1985). This reduction in elastin 
synthesis is accompanied by a seven-fold reduction in lysyl 
oxidase activity in the lung of those animals. This reduc-
tion in elastin synthesis and cross-linking may be of great 
pathophysiological signiﬁ  cance as emphysema lesions are 
exaggerated in hamsters exposed to cigarette smoke after 
elastase instillation (Hoidal and Niewoehner 1983).
Are alveolar regeneration and 
repair systems defective in human 
emphysema? Abnormal phenotype 
of ﬁ  broblasts
Whether a defect in alveolar regeneration systems plays a role 
in cigarette smoke induced emphysema in humans remains 
unclear but some elements indicate that such systems do get 
activated in the course of this disease. For instance, contrary 
to what is observed in the normal lung (Shapiro et al 1991), a 
high elastin turnover is observed in the emphysematous lung 
(Stone et al 1995; Gottlieb et al 1996; Vlahovic et al 1999), 
indicating that in parallel with the excessive degradation 
of elastic ﬁ  bers which is observed in this disease, elastin 
synthesis occurs in the lung. Interestingly, in line with a 
high rate of extracellular matrix synthesis associated with a 
high rate of extracellular matrix degradation, a high rate of 
cellular proliferation is associated with the elevated apoptosis 
of alveolar cells in the emphysematous lung (Imai et al 2005), 
adding more substance to the hypothesis that alveolar regen-
eration systems do get activated in the emphysematous lung 
even though they are probably not functional as the alveolar 
architecture is not restored. While an alteration of alveolar 
regeneration systems has not been directly evidenced in the 
emphysematous lung (Bonay et al 2005), it must be put for-
ward that alveolar ﬁ  broblasts exhibit a defective phenotype 
in the emphysematous lung.
Available data regarding the in situ phenotype of 
pulmonary ﬁ  broblasts in emphysema are limited to the obser-
vations by Sirianni and coworkers (Sirianni et al 2006). These 
authors showed that direct intercellular contacts between 
alveolar ﬁ  broblasts and alveolar epithelial cells or capillary 
endothelial cells are greatly reduced in the emphysematous 
lung. Those results suggest that pulmonary emphysema 
ﬁ  broblasts may lack the capacity to participate in the direct 
intercellular communications which play an essential role in 
fetal lung development and probably during lung repair in 
the lung (Warburton et al 2001; Parker et al 2004; Warburton 
and Bellusci 2004).
The abnormal phenotype of alveolar fibroblasts in 
pulmonary emphysema was described more extensively in 
vitro on primary lines of pulmonary ﬁ  broblasts obtained 
following the explant culture technique. First, pulmonary 
emphysema ﬁ  broblasts show signs of premature senescence. 
When compared to ﬁ  broblasts obtained from normal human 
lung, ﬁ  broblasts obtained from emphysematous lung have 
a markedly reduced proliferation rate. Indeed, emphysema 
ﬁ  broblast proliferation was described as 50%–60% of con-
trols (Nobukuni et al 2002; Noordhoek et al 2003; Holz 
et al 2004). In one study, those cells were shown to express 
senescence-associated beta-galactosidase (SA-beta-Gal), a 
marker of cellular senescence (Muller et al 2006). Moreover, 
in some studies emphysema ﬁ  broblasts did not exhibit the 
typical spindle-shaped microscopic appearance of ﬁ  broblasts 
and expressed smooth-muscle actin, indicating a degree 
of differentiation towards the myoﬁ  broblast phenotype. 
Secondly, in addition to premature senescence of pulmonary 
emphysema ﬁ  broblasts precluding an elevation of their num-
ber, those cells seem to secrete low levels of growth factors. 
In particular, HGF secretion by those cells is sharply reduced 
compared to normal lung ﬁ  broblasts and they poorly respond 
to exogenously added KGF (Plantier et al 2005). Given the International Journal of COPD 2007:2(4) 467
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potential regenerative effect of HGF and KGF in the lung, a 
low secretion of this factor by lung ﬁ  broblasts may play a role 
in the pathogenesis of emphysema. Altogether, those results 
indicate an altered phenotype of pulmonary ﬁ  broblasts which 
may partly contribute to the absence of alveolar regeneration 
observed in emphysema.
Alveolar regeneration systems are 
therapeutic targets for emphysema
The therapeutic manipulation of alveolar regeneration sys-
tems would represent a tremendous advance for the treat-
ment of emphysema as well as other diseases characterized 
by the destruction of alveoli. Such results were obtained in 
animal models of emphysema through the administration of 
pharmacological agents, gene therapy or the implantation 
of mesenchymal stem cells, raising hope that such an effect 
may be attainable in human patients.
The proof of concept that alveolar regeneration was a 
possible therapeutical goal in emphysema was brought by the 
pioneering work by Donald and Gloria Massaro (Massaro and 
Massaro 1997). In this study, all-trans retinoic acid induced 
partial alveolar regeneration 20 days after emphysema was 
induced in rats with the tracheal instillation of elastase. This 
result was reproduced by some groups (Ishizawa et al 2004), 
while others did not (Tepper et al 2000; Lucey et al 2003; 
Fujita et al 2004; March et al 2004).
The strong regenerative effect of exogenous HGF was 
shown in the elastase-induced emphysema model in mice. 
Its effect was associated to the engraftment into the lung 
of cells derived from the circulation (Ishizawa et al 2004). 
This effect was reproduced in rats transfected intravenously 
with the human HGF gene seven days after the instilla-
tion of elastase (Shigemura et al 2005). Adrenomedullin, 
an angiogenic factor, has been shown to possess alveolar 
regenerative properties in the same model, albeit at a lesser 
degree than HGF (Murakami et al 2005). Interestingly, an 
angiogenic stimulus seems necessary for the induction of 
alveolar regeneration in the emphysematous lung as KGF, 
which targets mainly epithelial cells, was not found to exert 
such an effect, even though its cytoprotective properties 
allowed it to fully prevent the constitution of emphysema in 
mice instilled with elastase (Plantier et al 2006).
All of the studies cited so far relied on the administration 
of soluble factors, either directly or by gene transfection. 
Another approach to the development of alveolar regenera-
tive therapeutics has been the transplantation into the lung 
of mesenchymal stem cells obtained from adipose tissue 
(Shigemura et al 2006a, 2006b). Adipose-tissue derived 
stromal cells were obtained from inguinal subcutaneous 
fat and applicated to the elastase-injured lung, resulting in 
alveolar regeneration and higher levels of PaO2 and maximal 
oxygen consumption. Interestingly, adipose-tissue derived 
stromal cells secrete particularly high levels of HGF. Their 
regenerative effect in the emphysematous lung may be related 
to this characteristic as their engraftment into the lung was 
not reported. Overall, the feasibility of inducing alveolar 
regeneration in rodents with elastase-induced emphysema 
has been thoroughly demonstrated.
Alveolar regeneration in human 
emphysema?
Whether alveolar regeneration may be obtained in pulmonary 
emphysema patients in the near future remains unsure. To 
this day, a single study has been devoted to the exploration of 
the effect of a regenerative agent in this disease, namely reti-
noic acid (Roth et al 2006). In this crossover study, all-trans 
retinoic acid, 13-cis retinoic acid or placebo were administered 
for 6 months to 148 patients with moderate-to-severe COPD 
and a predominant component of emphysema. Despite the 
fact that high plasma levels of retinoic acid were obtained in 
treated patients, no difference in pulmonary function or quality 
of life was observed between groups in this study.
Among the candidate drugs for regeneration therapy in 
the lung, HGF seems to be of particular interest. While the 
use of this factor for the treatment of lung disease has not 
been reported to date, encouraging preliminary results have 
been obtained in the treatment of peripheral arterial disease 
where HGF is well tolerated in the short term and induces an 
increase in distal perfusion (Morishita et al 2004). However, 
HGF has been reported to facilitate the growth of tumors in 
various organs, including the lung (Stabile et al 2006). Since 
patients with pulmonary emphysema are most frequently 
smokers or ex-smokers at a high risk of lung cancer, whether 
HGF itself is a good candidate for the long-term treatment 
of this disease remains to be evaluated.
Conclusion
Alveolar regeneration can be induced in animal models of dif-
fuse or localized alveolar loss and can be repressed by exposure 
to cigarette smoke. Defects in alveolar regeneration systems 
have been identiﬁ  ed in the human emphysematous lung and 
may play an important role in the course of this disease which 
is characterized by alveolar loss. Restoration and/or induction 
of these systems in emphysematous patients may represent a 
major advance in the treatment of pulmonary emphysema, 
a disease characterized by the loss of pulmonary alveoli. International Journal of COPD 2007:2(4) 468
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Encouraging results have been obtained in elastase-induced 
emphysema in rodents, and agents known to induce alveolar 
regeneration in this model are currently under evaluation for 
the treatment of emphysema and other diseases.
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